Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1160/week)
    • Manufacturing(569/week)
    • Technology(1126/week)
    • Energy(390/week)
    • Other Manufacturing(349/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Fibrinolysis

May 07, 2020
Applied BioMath, LLC Provides Systems Pharmacology Model to Support Fibrinolytic Therapy for Refractory COVID-19 Acute Respiratory Distress Syndrome
Mar 22, 2020
Liminal BioSciences comments on Coronavirus (COVID-19)
May 22, 2019
Prometic presents new PBI-4050 and Ryplazim(TM) (plasminogen) data on lung fibrosis at the 2019 ATS Conference
Apr 25, 2019
Now Available From Aniara Diagnostica, Aprotinin a Lyophilized Powder From Bovine Lung
Feb 28, 2019
American Regent Announces the Re-Introduction of Aminocaproic Acid Injection, USP; AP Rated and Therapeutically Equivalent to Amicar®*(1)
Oct 16, 2018
Prometic announces positive feedback from FDA Type-C meeting on Ryplazim(TM) (plasminogen) BLA
Jan 09, 2018
New Absorbable Adjunctive Hemostat From Ethicon Helps Surgeons Control Disruptive Bleeding More Efficiently
Dec 18, 2017
Prometic's Plasminogen (Ryplazim(TM)) granted orphan drug designation for the treatment of idiopathic pulmonary fibrosis (IPF)
Dec 06, 2017
Pivotal Data for Prometic's Intravenous Plasminogen Replacement Therapy to Be Presented at American Society for Hematology
Nov 01, 2017
Prometic receives clearance from the Swedish Medical Products Agency to initiate plasminogen clinical trial in chronic tympanic membrane perforation
Oct 26, 2017
Prometic receives clearance from the Swedish Medical Products Agency to initiate plasminogen diabetic foot ulcer Phase 2 clinical trial
Oct 19, 2017
Prometic Receives Priority Review Status From Health Canada for Plasminogen (Ryplazim(TM))
Oct 13, 2017
Prometic Announces FDA Acceptance of its Biologics License Application for Plasminogen (Ryplazim(TM))
Sep 18, 2017
TSI Completes Phase 1 Clinical Trial of Novel Clot-dissolving Therapy, TS01
Aug 29, 2017
Prometic Receives Rare Pediatric Disease Designation From U.S. FDA for its Plasminogen Replacement Therapy

Latest News

Jun 13, 2025

NOG Prices Upsized $175.0 Million Reopening of 3.625% Convertible Senior Notes Due 2029

Jun 13, 2025

Oklo Inc. Announces Pricing of Public Offering of Common Stock

Jun 13, 2025

AIRO Announces Pricing of Its Initial Public Offering

Jun 13, 2025

SINOVAC’s Board of Directors Issues a Letter to Shareholders Outlining Clear Pathway to Restore Fairness and...

Jun 13, 2025

Perma-Pipe International Holdings, Inc. Announces the Departure of David Mansfield and the Appointment of...

Jun 13, 2025

L'Otan booste ses dépenses, mais l'Europe saura-t-elle produire plus d'armes?

Jun 13, 2025

As NATO ups defence spending, can Europe produce the weapons?

Jun 13, 2025

Iran airspace closed until further notice: state TV

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia